Sloan Sheldon Insider Trading Activity
Sloan Sheldon has been net-selling over the last 12 months with 0 purchases and 8 sales across 1 company.
SYRE is the most-traded position with 8 trades. The largest single transaction was a sale of SYRE for $1.5M on May 1, 2026.
Performance Scorecard
Forward stock performance after each transaction by Sloan Sheldon. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -2.4% | 75% | 8 |
| 90 days | — | — | — | — |
| 120 days | — | — | — | — |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersSYRE · Spyre Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Sloan Sheldon bought and sold SYRE.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| May 1, 2026 | SYRE | Sell | 21,306 | $69.53 | $1.5M | Chief Medical Officer |
| May 1, 2026 | SYRE | Sell | 19,656 | $70.61 | $1.4M | Chief Medical Officer |
| May 1, 2026 | SYRE | Sell | 8,777 | $71.56 | $628K | Chief Medical Officer |
| May 1, 2026 | SYRE | Sell | 12,777 | $72.94 | $932K | Chief Medical Officer |
| May 1, 2026 | SYRE | Sell | 10,358 | $73.74 | $764K | Chief Medical Officer |
| May 1, 2026 | SYRE | Sell | 5,059 | $74.60 | $377K | Chief Medical Officer |
| May 1, 2026 | SYRE | Sell | 400 | $75.37 | $30K | Chief Medical Officer |
| Apr 1, 2026 | SYRE | Sell | 7,958 | $50.00 | $398K | Chief Medical Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | 8 | $6.0M |
Other insiders at Spyre Therapeutics, Inc.
3 other tracked filers at SYRE.